Luteolin treatment has been found to induce apoptosis in Bcl-2 overexpressing SW1990 pancreatic cancer cells via inhibiting Bcl-2 expression in a dose-dependent manner [135]. The gene discussed is BCL2; the disease is pancreatic neoplasm.